These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 19680127

  • 1. Agents and mechanisms of toxic myopathy.
    Kuncl RW.
    Curr Opin Neurol; 2009 Oct; 22(5):506-15. PubMed ID: 19680127
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Statin myopathy: an update.
    Christopher-Stine L.
    Curr Opin Rheumatol; 2006 Nov; 18(6):647-53. PubMed ID: 17053514
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Statin induced myotoxicity.
    Sathasivam S.
    Eur J Intern Med; 2012 Jun; 23(4):317-24. PubMed ID: 22560377
    [Abstract] [Full Text] [Related]

  • 7. Statin myopathy as a metabolic muscle disease.
    Phillips PS, Haas RH.
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):971-8. PubMed ID: 18666847
    [Abstract] [Full Text] [Related]

  • 8. Iatrogenic myopathies.
    Mastaglia FL.
    Curr Opin Neurol; 2010 Oct; 23(5):445-9. PubMed ID: 20581681
    [Abstract] [Full Text] [Related]

  • 9. Statin myotoxicity: a review of genetic susceptibility factors.
    Needham M, Mastaglia FL.
    Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Drug-induced and toxic myopathies].
    Coquet M, Bannwarth B, Henin D.
    Rev Prat; 2001 Feb 15; 51(3):278-83. PubMed ID: 11265424
    [Abstract] [Full Text] [Related]

  • 12. Update on toxic myopathies.
    Mastaglia FL, Needham M.
    Curr Neurol Neurosci Rep; 2012 Feb 15; 12(1):54-61. PubMed ID: 21968786
    [Abstract] [Full Text] [Related]

  • 13. Statin safety: lessons from new drug applications for marketed statins.
    Jacobson TA.
    Am J Cardiol; 2006 Apr 17; 97(8A):44C-51C. PubMed ID: 16581328
    [Abstract] [Full Text] [Related]

  • 14. Statin-associated myopathy and its exacerbation with exercise.
    Meador BM, Huey KA.
    Muscle Nerve; 2010 Oct 17; 42(4):469-79. PubMed ID: 20878737
    [Abstract] [Full Text] [Related]

  • 15. Drug-induced myopathies. An overview of the possible mechanisms.
    Owczarek J, Jasińska M, Orszulak-Michalak D.
    Pharmacol Rep; 2005 Oct 17; 57(1):23-34. PubMed ID: 15849374
    [Abstract] [Full Text] [Related]

  • 16. Statin induced myopathy.
    Frank RE.
    J Insur Med; 2009 Oct 17; 41(2):132-5. PubMed ID: 19845216
    [Abstract] [Full Text] [Related]

  • 17. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR, Jacobson TA.
    Curr Opin Lipidol; 2007 Aug 17; 18(4):401-8. PubMed ID: 17620856
    [Abstract] [Full Text] [Related]

  • 18. Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs.
    Nishimoto T, Ishikawa E, Anayama H, Hamajyo H, Nagai H, Hirakata M, Tozawa R.
    Toxicol Appl Pharmacol; 2007 Aug 15; 223(1):39-45. PubMed ID: 17599378
    [Abstract] [Full Text] [Related]

  • 19. Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization.
    Shanahan RL, Kerzee JA, Sandhoff BG, Carroll NM, Merenich JA.
    Pharmacotherapy; 2005 Mar 15; 25(3):345-51. PubMed ID: 15843281
    [Abstract] [Full Text] [Related]

  • 20. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M, Corsini A, Roden M.
    Eur J Clin Invest; 2015 Jul 15; 45(7):745-54. PubMed ID: 25991405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.